• to decrease the potential risk of severe cardiovascular (heart and blood vessel) challenges in Grownups with style two diabetes and cardiovascular disease In October 2024, Novo Nordisk published a research on scientific journal Nature about a novel glucose-sensitive insulin NNC2215 tha